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Background: Temporomandibular disorders (TMDs) are musculoskeletal conditions that can inhibit the normal 
function of temporomandibular joints (TMJs) and affect the patient’s quality of life, negatively. Arthrocentesis 
(AC) is a minimally invasive surgical procedure used for treating TMDs. The aim of present paper is to evaluate 
the advantages of administrating corticosteroid (CS) during AC by reviewing high quality released articles. 
Material and Methods: Searching on Cochrane Library, Web of Science, Google Scholar, PubMed, ProQuest, and 
Scopus databases were performed with focusing on proper key words. Related titles and abstracts, up to Decem-
ber 2017, were screened and selected based on inclusion criteria. The full text of all randomized controlled trials 
(RCTs) was extensively read and subjected to quality assessments. 
Results: After initial search, a total of 2067 articles were included into the study. Finally, 7 studies were reliable 
enough in methodology and randomization to be included into the study. All of the observed studies showed 
improvements in jaw functions and pain relief with no statistical differences in both AC and control groups. One 
study reported painless maximum incisal opening in CS group than the control group. 
Conclusions: Based on available RCTs, the AC of TMJ with CS seems to result in similar findings to other thera-
peutic drugs, with no significant differences.
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Introduction
Temporomandibular disorders (TMDs) are multifacto-
rial musculoskeletal conditions that alter the normal 
function of temporomandibular joints (TMJs), masti-
catory musculature, and surrounding soft tissues that 
might result in severe pain and limitation of normal 
jaw motions (1). Based on reports, about 5-12% of the 
general population suffer from the TMDs which is also 
mostly common in women (2). The consequences of 
TMDs can affect the patient’s quality of life (QoL) as 
TMJs are often solicited during daily activities such 
as chewing and speaking (3). The etiologies of TMDs 
are not consensus. Developmental situations, trauma, 
infection, immunologic conditions, and neoplasms are 
some of those suggested etiologies. Nevertheless, brux-
ism, clenching, stress, and malocclusion are the most 
common reasons of TMDs referred to the clinicians (4).
Several treatment strategies are introduced up to date. 
These treatments are also varied from conservative 
therapies to surgical procedures. Conservative thera-
pies are, for instance, occlusal splints therapy, myo-
function therapy, at home exercises, manual therapies, 
biofeedback and acupuncture (5). The exact mechanism 
of action of these therapies are not clarified yet. Some 
authors suggested combination of several peripheral, 
central and behavioral positive effects are as the result 
of these therapeutic methods (6). Decreased anxiety, de-
pression, pain intensity, muscle sensitivity, and cogni-
tive awareness are some possible effects of these treat-
ments (5). Arthrocentesis (AC) is another conservative 
treatment, like previous mentioned therapies, which can 
be ordered as both first or second line of treatment plan. 
During splint therapy, for instance, long term treatment 
period is ordered which might delay the achievement 
of efficient therapy and results in persistent soft tissue 
arthropathy. In this situation, the AC may have superior 
indication as first line treatment plan (7). Also, if other 
treatments failed, AC may be administered as second 
line of treatment plan (8). AC is a minimally invasive 
surgical treatment used for treating TMDs specially 
in patients with internal derangement of the TMJ. The 
AC procedure mostly relies on intra-articular wash-
ing with some therapeutic drugs such as normal sa-
line, corticosteroids (CS), Hyaluronic acid (HA) and 
etc. (9). Through AC procedure, the following impor-
tant substances might be washed away from the joint 
space: the microscopic necrotic tissue debris, inflam-
matory by-products, degraded tissues, and inflamma-
tory enzymes and mediators (10). One study investi-
gated the levels of interleukins (1β, 6, 8, and 11), and 
tumor necrosis factor-alpha in synovial fluid before 
and 2 weeks after AC (11). They stated that all of men-
tioned mediators were significantly decreased after 2 
weeks of observation. AC also stimulates the normal 
synovial secretion by lubricating and eliminating the 
inflammatory mediators which helps the TMJ to turn 
into its normal range of motion (10,11). Even by return-
ing the TMJ to its normal function, the regeneration 
and reconstruction process of articular tissues would 
be initiated after AC (10,11).
As mentioned above, different therapeutic drugs are 
suggested to be associated with AC. A recent system-
atic review, conducted by Goiato et al., evaluated the 
effects of using HA for AC (12). After final evaluation, 
they concluded that AC with HA is beneficial in im-
proving the pain and functional symptoms of TMDs. 
They recommended clinicians to evaluate the use of CS 
and non-steroidal anti-inflammatory drug to find more 
precise results in future studies (12).
CSs are anti-inflammatory drugs that interrupt the in-
flammatory and immune pathways. They have been 
used for both therapeutic and diagnostic purposes. 
Also, they showed their alleviating effects by suppress-
ing inflammatory responses (13). 
The intra-articular use of CS has been tested by some 
studies (14,15). Samiee et al. evaluated the use of intra-
articular injection of CS and local anesthesia in patients 
with disc displacement without reduction (14). Their 
final results were hopeful and positive responses were 
observed. Similar results were found by Giraddi et al. 
who evaluated the use of AC with CS in patents with 
internal derangements of TMJ (16). They proceeded AC 
with using Ringer lactate followed by injection of ei-
ther betamethasone or sodium hyaluronate into the TMJ 
space. They stated that both betamethasone and sodium 
hyaluronate showed similar results after AC (16).  In 
contrast, Olsen-Bergem and Bjørnland reported that the 
use of AC with CS is not useful in patents with TMD 
(17). They tried triamcinolone hexacetonide as the test 
CS in patients with juvenile idiopathic arthritis. They 
reported that adding a CS to AC procedure is not ben-
eficial enough (17).
As the data about the use of AC with CS seem to be 
sparse and there is no systematic review on this scope 
available, the aim of present review study is to answer 
the following PICO question (P: participant; I: interven-
tion; C: comparator; O: outcome): What are the effects 
of AC with CS in patients with any kinds of TMDs, com-
pared to other methods of TMD therapy, in improve-
ments of signs and symptoms? Also, the null hypothesis 
of this study was to assess whether administration of 
AC with CS leads to significant improvements of TMD 
symptoms rather than other therapeutic methods or not.
Material and Methods
-Study design:
To enhance structural reporting of the articles, the re-
viewing setting was in accordance to the Preferred Re-
porting Items for Systematic Reviews and Meta-Analy-
ses (PRISMA) guidelines (18). 
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PICO Key Words
Population (Temporomandibular Joint Disorders [MeSH Term]) OR (Temporomandibular Joint Disease [MeSH 
Term]) OR (Temporomandibular Joint Dysfunction Syndrome [MeSH Term]) OR (Temporomandibular 
Joint Degeneration)
Intervention  (Arthrocentesis [MeSH Terms]) OR (Temporomandibular Joint Arthrocentesis [MeSH Terms]) OR 
(Corticosteroid [MeSH Terms]) OR (Corticosteroid Arthrocentesis)
Comparison (Temporomandibular Joint treatment) OR (Splin [MeSH Terms]) OR (myofunction therapy [MeSH 
Terms]) OR (Biofeedback, Psychology [MeSH Terms]) OR (Ringer Lactate Arthrocentesis) OR (Hyal-
uronic Acid Arthrocentesis) OR (Intra articular injection)
Outcome (Clinical Success) OR (click) OR (Mouth Opening) OR (crepitus) OR (Prodromal Symptoms [MeSH 
Terms]) OR (Signs and Symptoms [MeSH Terms]) OR (Pain [MeSH Terms])
Table 1: Applied PICO keywords.
Firstly, a clinical question was defined for screening the 
qualified clinical studies based on PICO: Patients with 
any kinds of TMDs (P, population) who underwent AC 
with CS (I, intervention), compared to other methods of 
TMD therapy (C, comparison) that causes the improve-
ment of signs and symptoms (O, outcome).
A data search was performed using Cochrane Library, 
Web of Science, Google Scholar, PubMed, ProQuest, 
and Scopus databases of articles, based on the defined 
MeSH and non-MeSH terms in simple or multiple con-
junctions (Table 1). The searching procedure was con-
ducted manually up to December 2017, then Endnote 
software version 7 (Thomson Reuters, NY, USA) was 
used for final confirmation, cross matching, and avoid-
ing any missing of data. 
Two independent reviewers (A.D and F.A) qualified 
the eligible articles to review. To select the studies, all 
obtained English language reports were reviewed, and 
titles and abstracts were screened for relevance. The 
review articles and references from different studies 
were used to identify relevant articles. In the case of 
disagreement between reviewers, a discussion was un-
dertaken until mutual agreement was reached. Review-
ers’ agreement was tested with the Cohen κ test by use 
of MedCalc software (MedCalc Software, Ostend, Bel-
gium) (kappa score = 0.89).
The studies were subjected to Jadad Score Calculation 
for Critical Appraisal and lowering the risk of biases 
(19). They were classified as follow: 1-2 low quality, 3 
moderate, and 4-5 high quality (Table 2). The full text of 
relevant abstracts was obtained and selected using the 
following inclusion and exclusion criteria. 
-Inclusion criteria: 
• English language randomized clinical trials (RCTs) 
and prospective studies that investigated the effect of 
TMJ AC with CS
• Clinical research on at least 5 patients
• Maintaining the standard indications and guidelines 
of AC procedure 
• Performed at least one standard test for evaluating 




• Studies with missing data
• Repeatedly published studies; the last version was in-
cluded
• Studies in languages other than English
• Studies with Jadad score of < 3 (for eliminating the 
risk of biases)
The initial literature search yielded on 2067 articles 
(Cochrane Library=45/ Web of Science=5/ Google 
Scholar=1390/ PubMed=47/ ProQuest=107/ Sco-
pus=473), in which 1402 articles remained after remov-
ing duplicates. After the first screening based on the 
title and abstract, 11 studies (13,16,17,20-27) were found 
eligible which reached to 7 studies (13,17,20-24) after 
excluding high risk articles (Fig. 1). Full-texts of the all 
articles were reachable for initiating reviewing process. 
-Data extraction:
The following data were collected for each study: au-
thor, year, study design, participants (age, gender), 
method of TMD diagnosis, administered CS and dos-
age, the monitoring tests before and after AC, clinical 
significant outcomes. After gathering information, the 
possibility of preparing a meta-analysis was judged by 
an independent statistician and epidemiologist. As the 
collected data were vastly heterogeneous (like different 
corticosteroid drugs with different dosages, different 
diagnosis of TMD, different clinical test on the patients, 
and etc.) no meta-analysis were prepared.  
Results
A total of 2067 articles were included into the study 
after initial search. 1402 articles were remained after 
removing the duplicated ones of which 11 studies were 
eligible to be screened. The full texts of these articles 
were gathered and each one fulfilled the inclusion crite-
ria were observed. Relying on the Jadad scale (Table 2), 
three studies had a score of 5 (20-22), two had a score of 








































































































































































































































































































































































































































































Fig. 1: The flowchart of searching strategy based on PRISMA guide-
lines.
4 (23,24), and two had a score of 3 (13,17), for a total of 
7 high quality studies. The rests, which had low Jadad 
scale, were excluded from the study to avoid biases.
All of the reviewed studies were RCTs (13,20-24), in 
which two of them were single blinded (13,24), one co-
hort study (17), and the rests were double blinded (20-
23). The total number of patients enrolled in the studies 
was 397, ranging from 11 to 51 years old (Table 3).
Regarding the clinical problem, one study evaluated 
patients with arthralgia (22), two studies focused on os-
teoarthritis (13,23), one on internal derangement (24), 
one on Juvenile idiopathic arthritis (17), and the others 
observed TMDs with no specific disorder (20,21) (Table 
3). Among reviewed studies only 4 studies used the 
Wilkes classification criteria (13,20,21,23). All of these 
researches included patients with axis 1 group III for 
AC intervention. 
Regarding to the therapeutic methods and types of 
treatment (Table 4), three studies compared the use of 
HA with CS in their study groups (20,21,23), the others 
only investigated the effect of AC with CS compared 
to ringer lactate (13,20,21), or normal saline (22,23), or 
Vitamin B12 + physiological salt water (17), as a con-
trol medium. The follow-up period among the studies 
ranged from 1 month to 8 months.
Regarding to the studies’ outcomes, no consensus result 
was found about the paramount effect of using CS in AC 
for the treatment of TMDs (20,21). In a study by Comert 
Kilic S (13), the CS group, which received methylpred-
nisolone acetate along AC, exhibited better results in 
terms of painless maximum incisal opening (MIO) than 
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(23 F and 
5 M)
32.6 Clinical and 
imaging
Arthralgia
Manfredini et al. Double-blind 
RCT




(51 F and 
9 M)
51.1 Clinical and 
imaging
Osteoartheria
Comert Kilic S Single-blind 
RCT
Effect of CS  
following AC
32 TMJs in 
24 patients
(11 F and 10 
M)





Cohort RCT Effects of AC with 




38 TMJs in 
21 patients 
(15 F and 
6 M)




Bouloux et al. Double-blind 
RCT
Comparing effects of 
C  and HA following 
AC
102 patients 
(89 F and 13 
M)
45.2 Clinical and 
imaging
TMD
Bouloux et al. Double-blind 
RCT
Comparing effects of 
CS  and HA following 
AC on jaw function 
and quality of life
102 patients 
(89 F and 13 
M)
45.2 Clinical and 
imaging
TMD
Tabrizi et al. Single-blind 
RCT
Effect of CS  
following AC
60 patients
(47 F and 13 
M)




Table 3: Details of reviewed article .
the control group. In another study conducted by Man-
fredini et al. (23), all of the observed groups showed 
improvements in jaw functions and pain relief with no 
statistical differences, however the group 4, whom re-
ceived AC with high molecular weight HA injection, 
showed negative results (23). 
Although seven RCTs were included in this review, 
no systematic review or meta-analysis was performed 
about the efficacy of AC with CS with definite results.
Discussion
Recent systematic reviews on the effect of AC with HA 
(12), and intra-articular injection (not AC) of CS (28) 
have seemed effective for treatment of TMDs. How-
ever, no systematic review has been dedicated to the 
use of CS for AC. The null hypothesis of this study was 
to review whether administration of AC with CS leads 
to significant improvements of TMD symptoms rather 
than other therapeutic methods or not. Since there were 
no consensus findings among the screened studies, the 
null hypothesis was rejected. Nevertheless, the results 
do not deny the effectiveness of AC with CS in treat-
ments of TMDs and seems to have similar effectiveness 
like other methods. 
Based on Jadad scale, only 7 studies (out of 11) were 
reliable enough in methodology and randomization to 
be included in the study for avoiding any risk of biases.
Wilkes classified the TMDs and internal derangements 
of TMJ according to the clinical and radiological pro-
gressions as follow: early (I), early intermediate (II), 
intermediate (III), late intermediate (IV), and late (V) 
stages (29). Also, there is Research Diagnostic Criteria 
for Temporomandibular Disorders (RDC/TMD) vali-
dation project for comprehensive assessment of TMD 
classification (30). All of the four studies, which used 
Wilkes criteria, enrolled patients with Axis 1 group III. 
The Axis 1 is categorized into 3 subgroups: group I: 
muscle disorders; II: disk displacements; III: Arthral-
gia, Arthritis, Arthrosis (30). 
As mention before, AC eliminates the inflammatory by-
products of synovial fluids and stimulates the normal 
lubrication properties of synovial membrane (31).
The anti-inflammatory role of CS is through interrupt-
ing immunological pathways which has been proved in 
medical texts (32, 33). CS therapy affects the synovial 
tissues by suppressing the inflammatory molecules and 
passing through the cellular membrane and binding to 
CS receptors located in the cytoplasm. These activated 
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Author Types of treatments Clinical tests Follow ups outcomes
Huddleston Slater 
et al.
Group 1: 2-needle AC with 1 ml dexamethasone
Group 2: 2-needle AC with 1 ml saline
VAS; MIO; 
MFIQ
After 1, 3, 24 
weeks
Both groups showed similar 
clinical effects
Manfredini et al. Group 1: 2-needle AC with 300 ml saline (11 
patients)
Group 2: 2-needle AC with 300 ml saline + 1.0 
ml triamcinolone injection
(9 patients)
Group 3: 2-needle AC with 300 ml saline + 1.0 
ml low MW HA injection (11 patients)
Group 4: 2-needle AC with 300 ml saline + 1.0 
ml high MW HA injection (5 patients)
Group 5: 5 weekly 2-needle AC with 300 ml sa-
line + 1.0 ml low MW HA injection (12 patients)
Group 6: 5 weekly 1-needle
AC with 300 ml saline + 1.0 ml low MW HA 
injection
VAS; 5 point 
Likert type; 
jaw motion
3 months Groups 1, 2, 3, 5, and 6:
improvement in clinical
symptoms
Comert Kilic S Group 1: AC with ringer lactate
Group 2: AC with 1ml methylprednisolone 
acetate
VAS; MIO; jaw 
motion; joint 
noise
TMJ noise and pain 
decreased in both groups
Painless MIO in group 2
Olsen-Bergem H and 
Bjørnland T
Treatment A: AC with VitB12 + physiological 
salt water
Treatment B: AC with VitB12 + physiological 




After 3 and 8 
months
Pain on opening and lateral 
excursion improved.
Decreased VAS results.
No difference between the 
tested treatment protocols.
Bouloux et al. Group 1: 2-needle AC with 1 ml HA
Group 2: 2-needle AC with 1 ml celestone (6mg/
ml betamethasone)
Group 3: 2-needle AC with 1 ml ringer lactate
VAS;
MIO
After 1 and 3 
months
No significant difference in 
TMJ pain among groups
Bouloux et al. Group 1: 2-needle AC with 1 ml HA
Group 2: 2-needle AC with 1 ml celestone (6mg/
ml betamethasone)
Group 3: 2-needle AC with 1 ml ringer lactate





After 1 and 3 
months
No significant difference 
among groups in all of the 
examined parameters
Tabrizi et al. Group 1: AC with ringer lactate







After 1 and 6 
months
All of the measured 
parameters were similar 
between both groups
Table 4: Study grouping, clinical tests, and clinical significant results of reviewed articles. 
Arthrocentesis (AC), Hyaluronic acid (HA), Molecular weight (MW), Visual Analog Scaling (VAS), Maximum incisal opening (MIO), Jaw 
Function Limitation Scale (JFLS), Mandibular Function Impairment Questionnaire (MFIQ).
receptors eliminate the expression of pro inflammatory 
cytokines, enzymes, and inflammatory process (13). 
One of the most important anti-inflammatory mecha-
nism seems to be related to the upregulation and pro-
duction of lipocortin 1. In consequence, the phospho-
lipase A2, cyclooxygenase 1 and 2, and lipooxygenase 
are blocked which leads to decrease in the production 
of prostaglandins, prostacyclins, and leukotrienes (20).
Recent tissue culture researches on the effects of CSs 
revealed that they are capable to depress the degradation 
of cartilage harvested from patients with osteoarthritis 
and rheumatoid arthritis. The inhibition of various in-
flammatory mediators and decrease in the activity of 
proteolytic enzymes might be the main reason (13).
Methylprednisolone acetate, triamcinolone hexaceton-
ide, triamcinolone acetonide, betamethasone acetate, 
betamethasone sodium phosphate, betamethasone di-
propionate, betamethasone sodium phosphate are the 
most administered intra-articular CSs (34). Amongst 
them, betamethasone is more administered for intra ar-
ticular injection in TMDs, however methylprednisolone 
acetate, which is more prescribed in the United States, 
is mostly associated with triamcinolone hexacetonide 
and triamcinolone acetonide for intra articular injec-
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tions (35). Among the reviewed studies, betamethasone 
was used in two studies (20,21), and methylpredniso-
lone acetate was injected in one study (13). The others 
used dexamethasone (22,24) and triamcinolone (17,23). 
Some studies declared that methylprednisolone acetate 
represents better healing potential on articular surfaces. 
It also is more soluble with prolonged effectiveness (36). 
However, in a recent in vivo study, the cytotoxicity of 
betamethasone acetate, methylprednisolone acetate, tri-
amcinolone acetonide were compared and the results 
manifested that betamethasone acetate and methylpres-
dnisolone acetate were chondrotoxic and synoviotoxic 
in contrast to triamcinolone which caused more viable 
effects (37). 
Huddleston et al. tried dexamethasone for AC with this 
rationale that it modifies the vascular regeneration by 
eliminating both destructive enzymes and the actions 
of inflammatory cells (22). However, their results did 
not show either positive or negative effects of dexa-
methasone. They believed that uncertainty in the work-
ing time of dexamethasone, which is about 36-72 hours, 
makes the long term benefits become unexpected. They 
also suggested using of triamcinolone as a long lasting 
CS in future studies (22).
Manfredini et al., tried six different treatment proto-
cols for patient with osteoarthritis to observe the im-
provement of nociceptive and functional symptoms 
(23). The drugs associated with AC were CS (triam-
cinolone) (group 2), low molecular weight HA (groups 
3, 5, and 6), and high molecular weight HA (group 4). 
The treatments for group 4 resulted in unpleasant side 
effects which convinced authors to interrupt the treat-
ment course. Because of the low intra articular space, 
the high molecular weight HA could not diffuse easily 
within the TMJ intra articular space. All other groups 
showed improvements in examined factors (MIO, 
chewing efficiency, pain at rest and in motion) with no 
significant differences (23).
In another study, Comert Kilic S studied the effect of 
AC with or without CS (methylprednisolone acetate) on 
osteoarthritis. The study was conducted on 32 joints of 
24 patients and the final result revealed that the TMJ 
pain and joint sounds were statistically decreases in 
both groups, while the painless MIO was statistically 
improved only the CS group (13). The role of CS in im-
provement of MIO was similar between study groups 
in all of the reviewed articles except for Songul et al. 
who noted significant effect of AC with CS in MIO. 
That might be due to reduction of pain and inflamma-
tory modulators which helps to release the adhered disk 
by elimination of negative pressure and surface friction 
(38). 
Olsen-Bergem H and Bjørnland T (17) tried Vitamin 
B12 for AC in patients with Juvenile idiopathic arthritis. 
The Vitamin B12 is not generally considered as an anti-
inflammatory agent. They did not specify the reason of 
using vitamin B12 during AC but they claimed that this 
treatment protocol is according to Alstergren P et al. 
study (39). During a meticulous overview on the Alster-
gren P et al. study, it was found that the Vitamin B12 
was used as a mediator and indicator in measuring the 
interleukin 1β in the synovial fluid obtained from TMJs 
with arthritis (39). Olsen-Bergem H and Bjørnland T 
did not analyze any kind of inflammatory mediators in 
their methodology. Although the vitamin B12 might not 
have negative effects on the AC procedure or treatment 
sequence of TMDs, the researches supposed to be well 
aware about the purpose and properties of each drugs 
which is going to be administered in their study groups.
 Relying on the gathered information, most of the re-
viewed studies stated no significant effect of AC with 
CSs. The reason is not definite but some factors might 
be involved: the AC procedure before CSs injection 
might council the positive effects of CS (13), also the 
main reason of positive outcomes might be due to the 
pressure of lavage in AC not the pharmaceutical prop-
erties of used drugs (24). Moreover, direct comparison 
among studies in which AC has been administered for 
one of the study groups is not accurate enough because 
the AC technique is not standardized and inclusion cri-
teria might differ from one study to another (20).
As mentioned before, the TMDs might have negative 
impacts on patient’s QoL. Tjakkes et al. overviewed 
the role of TMDs in patients’ QoL. They observed 95 
patients and the results manifested that TMD pain less 
than one year did not influence the Qol significantly. 
However, in longer duration of pain, social function of 
patients was significantly decreased. In these cases, the 
mental health scores and emotional problems were not 
seriously affected (3). One of the reviewed studies, by 
Bouloux et al. (21), focused on the role of AC in pa-
tients’ QoL by evaluating some factors such as: Jaw 
Function Limitation Scale, MIO, mental health, and so-
cial functions. They revealed that the HA group showed 
an improvement in the physical health. Also, the control 
group (Ringer Lactate) showed an improvement in the 
mental health, however their results were not statistical-
ly significant. MIO without pain was improved among 
all of the studied groups with no significant differences. 
However, after one month follow up, the improvements 
were significant only in the CS and HA groups. The 
MIO results were similar after 3 months among all of 
the groups.
The side effects of AC:
The AC procedure is one of the minimally invasive sur-
gical procedure. Nevertheless, The AC procedure might 
cause some side effects. Some of the reported complica-
tions are: pharyngeal edema, vascular and otologic and 
neurologic injuries, perforation of the middle cranial 
fossa, extradural hematoma (40). Ahmed et al. reported 
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that one patient, out of 244 patients, was followed up for 
24 h after TMJ AC due to vocal fold edema. They stated 
that through the medial joint capsule perforation follow-
ing the extravasation of fluid was the main reason of 
edema (41). Nerve injuries mostly involve facial nerve 
injury (0.7–0.6 %), trigeminal nerve injury (0.1–2.4 %), 
otic injury (0.5–8.6 %) (42). Also, transient facial pa-
ralysis as a consequence of the local anesthetic infusion 
and the following alteration of motor function at the side 
of AC is one of the possible side effects (43). 
Limitations:
One of the main obstacles upon us was the heteroge-
neous gathered data which prevented us to prepare a 
meta-analysis, however the results of reviewed studies 
were not too different form each other and making fi-
nal conclusion was not difficult. The studies in which 
compare the other lavage agents such as HA were not 
available enough, either.
Conclusions
According to the available RCTs on the role of CS dur-
ing AC of TMJ, no significant result was found among 
CS groups and other groups (either control or other 
drugs). Although, reliable documents on effectiveness 
of CSs during AC of TMJ are not vast enough for mak-
ing more determinant conclusion, it seems that CSs 
do not present better properties than other therapeutic 
drugs during AC. Nevertheless, dedicating more RCTs 
on this subject alongside with other methods and drugs 
are suggested in future researches.
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